Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2007

Thermo Fisher Scientific Acquires NanoDrop Technologies

  • Thermo Fisher Scientific reported the take-over of NanoDrop Technologies. The acquisition will expand the company’s portfolio of microvolume ultraviolet-visible (UV-Vis) instruments for applications involving small sample volumes.

    “Growing demand from our laboratory customers to accelerate sample-preparation time is now compounded by the need to work with smaller sample sizes,” points out Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. “NanoDrop's patented technologies uniquely allow customers to quickly and easily analyze difficult microvolume samples without the need for dilution. This preserves precious samples to greatly increase laboratory productivity.”

    NanoDrop is based in Wilmington, DE. The firm has annual revenues of approximately $35 million, according to Thermo Fisher Scientific. The transaction will add three tools - the NanoDrop® ND-1000 and ND-8000 UV-Vis spectrophotometers and the NanoDrop ND-3300 fluorescence spectrophotometer.

    The NanoDrop product line will be integrated into Thermo Fisher's scientific instruments business, part of its Analytical Technologies Segment. They will be marketed under the company's Thermo Scientific technology brand.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »